Abstract:Objective To investigate the effects of plumbagin on human NL9980 large-cell lung cancer cells and the role of interleukin-6/signal transducers and activators of transcription 3 (IL-6/ STAT3) signaling pathway in the anticancer procedure of plumbagin.Methods Different concentrations of plumbagin were administrated in NL9980 cell line.Inhibitory effects of plumbagin on NL9980 cells were analyzed using methyl thiazol tetrazolium (MTT) assay.Groups of different drug doses (5.0,7.5,10.0μmol/L) and blank control (without administration of plumbagin) were set with simple random sampling method.Cells were collected after 24 h of administration.Expression of IL-6 and STAT3 and the downstream genes B-cell lymphoma/leukemia-2 (bcl-2),vascular endothelial growth factor (VEGF),and Cyclin D1 were assessed by real-time quantitative polymerase chain reaction (Real-time PCR).Enzyme linked immunosorbent assay (ELISA) was used to measure secreted IL-6 levels and western blotting to measure intracellular phospho-STAT3 levels.Results Plumbagin significantly inhibited NL9980 cells via suppressing IL-6/STAT3 signaling.Expression of all genes was inhibited by plumbagin in a dose-dependent manner (F =32.170,P =0.000).As the concentration of plumbagin increased,the expression of IL-6 mRNA decreased significantly (F =173.067,P =0.000) to 0.50 ± 0.02,0.44 ± 0.1,0.34 ± 0.04 respectively and IL-6 protein decreased to 4.71 ± 0.02,4.08 ± 0.14,2.01 ± 0.07 significantlly (F =1 805.177,P=0.000).Besides,the expression of STAT3 mRNA (0.86 ±0.08,0.72 ±0.03,0.52 ± 0.06,F=230.918,P=0.000) and protein (0.65 ±0.19,0.45 ±0.22,0.31 ±0.11,F=17.332,P=0.000) were reduced with the increase of concentration of plumbagin.Compared with the control group,expression of downstream genes bcl-2,VEGF and Cyclin D1 mRNA were decreased significantly after administration of plumbagin (F=33.698,P=0.000;F=337.743,P=0.000;F=180.136,P=0.000),and declined gradually as drug concentration increased.Moreover,bcl-2,VEGF,and Cyclin D1 mRNA levels positively correlated with levels of IL-6 and STAT3 gene expressions.Conclusion IL-6-mediated STAT3 suppression decreased bcl-2,VEGF,and Cyclin D1 expression.Thus,plumbagin may be an effective therapy for large-cell lung cancer that acts by targeting the IL-6/STAT3 signaling pathway.

Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2

Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Suppressing the Migration and Invasion of Tumor-Derived Vascular Endothelial Cells

Plumbagin Suppresses Endothelial Progenitor Cell-Related Angiogenesis in Vitro and in Vivo

Plumbagin Shows Anti-Cancer Activity in Human Breast Cancer Cells by the Upregulation of P53 and P21 and Suppression of G1 Cell Cycle Regulators

Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances

Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells Via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions

Plumbagin, a Medicinal Plant (lumbago Zeylanica)‐derived 1,4‐naphthoquinone, Inhibits Growth and Metastasis of Human Prostate Cancer PC‐3M‐luciferase Cells in an Orthotopic Xenograft Mouse Model

Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA

Dddt_a_200610 1289..1300

Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition

Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells

Research of the inhibitory effect and the mechanisms of plumbagin on large cell lung cancer NL9980 cell line

Plumbagin Suppresses Epithelial to Mesenchymal Transition and Stemness Via Inhibiting Nrf2-mediated Signaling Pathway in Human Tongue Squamous Cell Carcinoma Cells.

Plumbagin induces ferroptosis in colon cancer cells by regulating p53-related SLC7A11 expression

Research on the anti-tumor effect of Plumbagin against human highly metastatic large cell lung cancer cell line

Plumbagin Has an Inhibitory Effect on the Growth of TSCC PDX Model and It Enhances the Anticancer Efficacy of Cisplatin.

Plumbagin induces RPE cell cycle arrest and apoptosis via p38 MARK and PI3K/AKT/mTOR signaling pathways in PVR

Plumbagin Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR-mediated Pathway in Human Pancreatic Cancer Cells

In-vitro Studies of Extracts of Plumbago Zeylanica in Cancer Cell Lines

Platycodin D Inhibits Tumor Growth by Antiangiogenic Activity Via Blocking VEGFR2-mediated Signaling Pathway

Bioinformatic and Experimental Data Decipher the Pharmacological Targets and Mechanisms of Plumbagin Against Hepatocellular Carcinoma.